MoonLake Immunotherapeutics (MLTX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$20.90

Buy

$21.29

arrow-down$-0.94 (-4.24%)

Prices updated at 24 Jun 2026, 00:27 EDT

Prices minimum 15 mins delay

Prices in USD

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiti ...

NASDAQ

-2.21%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$22.32 - $20.65
	$62.75 - $5.95
	-
	1,631.32m
	-
	-
	1,737,498
	6.15
	2,242,572.01
	0.88
	71.37m
	KY61559X1045
	-3.88
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.